203 related articles for article (PubMed ID: 37199024)
1. SESN1 is a FOXO3 effector that counteracts human skeletal muscle ageing.
Jing Y; Zuo Y; Sun L; Yu ZR; Ma S; Hu H; Zhao Q; Huang D; Zhang W; Belmonte JCI; Yu Y; Qu J; Liu GH; Wang S
Cell Prolif; 2023 May; 56(5):e13455. PubMed ID: 37199024
[TBL] [Abstract][Full Text] [Related]
2. Single-nucleus profiling unveils a geroprotective role of the FOXO3 in primate skeletal muscle aging.
Jing Y; Zuo Y; Yu Y; Sun L; Yu Z; Ma S; Zhao Q; Sun G; Hu H; Li J; Huang D; Liu L; Li J; Xin Z; Huang H; Belmonte JCI; Zhang W; Wang S; Qu J; Liu GH
Protein Cell; 2023 Jun; 14(7):497-512. PubMed ID: 36921027
[TBL] [Abstract][Full Text] [Related]
3. Foxo3 Knockdown Mediates Decline of
Gellhaus B; Böker KO; Gsaenger M; Rodenwaldt E; Hüser MA; Schilling AF; Saul D
Cells; 2023 Aug; 12(17):. PubMed ID: 37681900
[TBL] [Abstract][Full Text] [Related]
4. Regulation of muscle atrophy-related genes by the opposing transcriptional activities of ZEB1/CtBP and FOXO3.
Ninfali C; Siles L; Darling DS; Postigo A
Nucleic Acids Res; 2018 Nov; 46(20):10697-10708. PubMed ID: 30304480
[TBL] [Abstract][Full Text] [Related]
5. Skeletal muscle-specific Prmt1 deletion causes muscle atrophy via deregulation of the PRMT6-FOXO3 axis.
Choi S; Jeong HJ; Kim H; Choi D; Cho SC; Seong JK; Koo SH; Kang JS
Autophagy; 2019 Jun; 15(6):1069-1081. PubMed ID: 30653406
[TBL] [Abstract][Full Text] [Related]
6. 20(s)‑ginseonside‑Rg3 modulation of AMPK/FoxO3 signaling to attenuate mitochondrial dysfunction in a dexamethasone‑injured C2C12 myotube‑based model of skeletal atrophy
Wang M; Jiang R; Liu J; Xu X; Sun G; Zhao D; Sun L
Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33649814
[TBL] [Abstract][Full Text] [Related]
7. Triptolide induces atrophy of myotubes by triggering IRS-1 degradation and activating the FoxO3 pathway.
Wang J; Gao X; Ren D; Zhang M; Zhang P; Lu S; Huan C; Yao Y; Zheng L; Bao Z; Zhou J
Toxicol In Vitro; 2020 Jun; 65():104793. PubMed ID: 32061799
[TBL] [Abstract][Full Text] [Related]
8. miR-182 attenuates atrophy-related gene expression by targeting FoxO3 in skeletal muscle.
Hudson MB; Rahnert JA; Zheng B; Woodworth-Hobbs ME; Franch HA; Price SR
Am J Physiol Cell Physiol; 2014 Aug; 307(4):C314-9. PubMed ID: 24871856
[TBL] [Abstract][Full Text] [Related]
9. Matrine improves skeletal muscle atrophy by inhibiting E3 ubiquitin ligases and activating the Akt/mTOR/FoxO3α signaling pathway in C2C12 myotubes and mice.
Chen L; Chen L; Wan L; Huo Y; Huang J; Li J; Lu J; Xin B; Yang Q; Guo C
Oncol Rep; 2019 Aug; 42(2):479-494. PubMed ID: 31233199
[TBL] [Abstract][Full Text] [Related]
10. CARM1 contributes to skeletal muscle wasting by mediating FoxO3 activity and promoting myofiber autophagy.
Liu Y; Li J; Shang Y; Guo Y; Li Z
Exp Cell Res; 2019 Jan; 374(1):198-209. PubMed ID: 30500392
[TBL] [Abstract][Full Text] [Related]
11. DBC1 maintains skeletal muscle integrity by enhancing myogenesis and preventing myofibre wasting.
Liang N; He J; Yan J; Han X; Zhang X; Niu Y; Sha W; Li J
J Cachexia Sarcopenia Muscle; 2024 Feb; 15(1):255-269. PubMed ID: 38062876
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic Consequences of Targeting the IGF-1/PI3K/AKT/FOXO3 Axis in Sarcopenia: A Narrative Review.
Gellhaus B; Böker KO; Schilling AF; Saul D
Cells; 2023 Dec; 12(24):. PubMed ID: 38132107
[TBL] [Abstract][Full Text] [Related]
13. 20(S)-ginsenoside Rg3 promotes myoblast differentiation and protects against myotube atrophy via regulation of the Akt/mTOR/FoxO3 pathway.
Wang M; Ren J; Chen X; Liu J; Xu X; Li X; Zhao D; Sun L
Biochem Pharmacol; 2020 Oct; 180():114145. PubMed ID: 32653593
[TBL] [Abstract][Full Text] [Related]
14. Protein Hydrolysate from
Lee CW; Chang YB; Park CW; Han SH; Suh HJ; Ahn Y
Mar Drugs; 2022 May; 20(6):. PubMed ID: 35736168
[TBL] [Abstract][Full Text] [Related]
15. β2-adrenergic receptor agonist counteracts skeletal muscle atrophy and oxidative stress in uremic mice.
Higashihara T; Nishi H; Takemura K; Watanabe H; Maruyama T; Inagi R; Tanaka T; Nangaku M
Sci Rep; 2021 Apr; 11(1):9130. PubMed ID: 33911115
[TBL] [Abstract][Full Text] [Related]
16. SMAD3 augments FoxO3-induced MuRF-1 promoter activity in a DNA-binding-dependent manner.
Bollinger LM; Witczak CA; Houmard JA; Brault JJ
Am J Physiol Cell Physiol; 2014 Aug; 307(3):C278-87. PubMed ID: 24920680
[TBL] [Abstract][Full Text] [Related]
17. MiR-1290 promotes myoblast differentiation and protects against myotube atrophy via Akt/p70/FoxO3 pathway regulation.
Che J; Xu C; Wu Y; Jia P; Han Q; Ma Y; Wang X; Zheng Y
Skelet Muscle; 2021 Mar; 11(1):6. PubMed ID: 33722298
[TBL] [Abstract][Full Text] [Related]
18. Cellular senescence and disrupted proteostasis induced by myotube atrophy are prevented with low-dose metformin and leucine cocktail.
Petrocelli JJ; de Hart NMMP; Lang MJ; Yee EM; Ferrara PJ; Fix DK; Chaix A; Funai K; Drummond MJ
Aging (Albany NY); 2023 Mar; 15(6):1808-1832. PubMed ID: 36947713
[TBL] [Abstract][Full Text] [Related]
19. Forkhead box O3 promotes cell proliferation and inhibits myotube differentiation in chicken myoblast cells.
Lee JH; Park JW; Kang KS; Park TS
Br Poult Sci; 2019 Feb; 60(1):23-30. PubMed ID: 30427204
[TBL] [Abstract][Full Text] [Related]
20. Physical inactivity induces the atrophy of skeletal muscle of rats through activating AMPK/FoxO3 signal pathway.
Zhang SF; Zhang Y; Li B; Chen N
Eur Rev Med Pharmacol Sci; 2018 Jan; 22(1):199-209. PubMed ID: 29364488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
